At present, researchers have an abundance of real-world data. Although these data have been primarily used for safety surveillance, they are increasingly used in regulatory and reimbursement decisions. Now, the COVID-19 pandemic is accelerating the use of real-world evidence analyses despite a dearth of evidence on whether decisions based on such analyses are clinically accurate or reliable.
“My mantra is you have to use the right data to answer the right question. If you don’t understand what the data are telling you, you could get some misinformation and potentially some harmful decision making, as is being seen now with COVID-19, ” says Dr. Nirosha Mahendraratnam Lederer, Managing Associate at the Duke-Margolis Center for Health Policy, Durham, NC, USA. Read more here.
(Source: ISPOR Spotlight, 10/20/20)